FDAnews
www.fdanews.com/articles/72307-lonza-wins-six-year-supply-contract-from-ucb

Lonza Wins Six-Year Supply Contract From UCB

May 13, 2005

Lonza AG, the Swiss chemical and pharmaceutical industry supplier, said it has won a six-year contract from UCB SA to supply the Belgian group with PEGylated antibody fragment based bulk actives. Financial details were not disclosed. Lonza is building a commercial scale biopharmaceutical manufacturing facility in Visp, Switzerland, to handle the order, which is scheduled to be operational in the second half of 2006. Under the terms of the agreement UCB has reserved a fixed annual manufacturing capacity for recombinant microbial products, covering the period 2006-2012, with an option to extend, Lonza said.

Forbes (http://www.forbes.com/business/feeds/afx/2005/05/13/afx2024828.html)